Nuvectis Pharma Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$19.08

+0.21 (+1.09%)

As of Aug 15, 2:08 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +43.6% upside

Low Target $23.46

Average Target $27.40

High Target $40.51

Current Price $19.08

Current
$19.08

Target
$27.40

$23.46 $27.40 avg $40.51

Scenario Analysis

Bear Case

$23.46

23.0%

Low target

Base Case

$27.40

+43.6%

Avg target

Bull Case

$40.51

+112.3%

High target

Risk/Reward

4.9x

Highly favorable

Price in Context

52-Week High

$29.28

-34.8% from high

52-Week Low

$5.55

+243.8% from low

Target vs 52W High

$27.40

-6.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%